Brain Monitoring Market worth $4.8 billion by 2028
The report "Brain Monitoring Market by Devices (EEG, EMG, MEG, ICP, MRI, fMRI, CT) Accessories (Electrode, Sensor), Modality (Portable, Wearable), Indication (Stroke, TBI, Epilepsy, Headache, Sleep), End User (Hospital, Neurology center) - Global Forecast to 2028", size is estimated to be USD 4.8 billion by 2028 from USD 3.5 billion in 2023, at a CAGR of 6.3%. Factors propelling the brain monitoring market include the escalating occurrence and prevalence of neurological disorders, heightened awareness surrounding neurodegenerative diseases, an uptick in traumatic brain injuries, and expanding utilization of brain monitoring in clinical trials.
Browse 321 market data Tables and 54 Figures spread through 348 Pages and in-depth TOC on "Brain Monitoring Market by Devices (EEG, EMG, MEG, ICP, MRI, fMRI, CT) Accessories (Electrode, Sensor), Modality (Portable, Wearable), Indication (Stroke, TBI, Epilepsy, Headache, Sleep), End User (Hospital, Neurology center) - Global Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/brain-monitoring-devices-market-909.html
The accessories segment is expected to register the highest growth of the brain monitoring market
By product, the global brain monitoring market is categorized into devices and accessories. The accessories segment is expected to register the growth of the brain monitoring market in 2022. The growing population, increasing incidence of neurological disorders, technological advancements, and the rising adoption of novel accessories are expected to propel the growth of this market.
Non-invasive procedures accounted for the largest share of the brain monitoring market
By procedure, the global brain monitoring market is categorized into invasive and non-invasive. The non-invasive segment held the largest share of the brain monitoring market in 2022. Primarily attributed to the factors such as non-invasive techniques are associated with lower risks of complications, infections, and side effects compared to invasive procedures. This safety profile makes them more favorable, especially in cases where continuous or repeated monitoring is required.
Fixed devices accounted for the largest share of the modality segment of the brain monitoring market
By modality, the global brain monitoring market is categorized into fixed, portable, and wearable. The fixed devices held the largest share of the brain monitoring market in 2022. This is due to their established presence and usage in clinical settings such as hospitals, specialized healthcare facilities, and research institutions. These fixed devices are often considered the standard for comprehensive brain monitoring due to their accuracy, reliability, and advanced functionalities.
The traumatic brain injury segment accounted for the largest share of the brain monitoring market in 2022.
Based on medical condition, the brain monitoring market is segmented into traumatic brain injury (TBI), stroke, dementia, headache disorders, sleep disorders, Parkinson’s disease, epilepsy, Huntington’s disease, and other diseases. Traumatic brain injury (TBI) holds the largest share of the brain monitoring market by a medical condition. One of the primary drivers contributing significantly to the substantial market share of this segment is the increasing global prevalence of Traumatic Brain Injuries (TBIs). This surge in TBIs creates a considerable demand for managing such cases, necessitating the extensive utilization of brain monitoring devices.
Hospitals accounted for the largest share of the end user segment of the brain monitoring market
Based on end-users, the global brain monitoring devices market is segmented into hospitals, neurology centers, diagnostic centers, ASCs & and clinics, and other end users. The hospital segment held the largest global brain monitoring market share in 2022. Brain monitoring necessitates intricate procedures involving costly and sophisticated devices primarily available within hospital settings. Hospitals experience notably higher patient volumes than smaller clinics and other end users. Moreover, the maintenance expenses associated with brain monitoring devices substantially burden healthcare facilities, and hospitals, in particular, can manage such costs. As a result, brain monitoring devices find predominant use in hospitals, contributing to their dominance and larger market share within this segment.
North America accounted for the largest share of the global brain monitoring market
Based on region, the brain monitoring market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa, Latin America, and Middle East & Africa. North America held the largest share of the global brain monitoring market in 2022, while Asia Pacific is projected to be the fastest-growing region in the forecast period. The large share of North American brain monitoring market is due to growing number of clinical trials of brain monitoring products, availability of medical reimbursement in US, large patient population for target diseases, the strong presence of device manufacturers in the region, and the availability of significant R&D investments to support brain monitoring development.
Some of the leading players in the Brain Monitoring market include Advanced Brain Monitoring (US), Masimo Corporation (US), Unilabs Holdings AB (Sweden), Cadwell Industries (US), NeuroWave Systems, Inc. (US), Siemens Healthineers (Germany), Compumedics, Ltd. (Australia), Medtronic (Ireland), Luciole Medical AG (Switzerland), Drägerwerk AG & Co. KGaA (Germany), Natus Medical, Inc. (US), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (US), Nonin Medical, Inc. (US), Integra LifeSciences Corporation (US), and Neurosoft (Russia).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Brain Monitoring Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
